U.S. Banks Stock News

McKesson (NYSE:MCK) announced that EVP and CFO Britt Vitalone will retire. Kenny Cheung has been named incoming CFO, effective May 29, 2026. The transition shifts responsibility for McKesson's financial leadership and capital decisions to Cheung on that date. For investors watching McKesson at a share price of $871.18, this CFO change comes after a 1 year return of 30.2% and a 5 year gain of about 4.7x. The company has also recorded a 3 year return of 143.7%, while year to date performance...

FactSet Research Systems (NYSE:FDS) has appointed Joshua B. Warren as its new Chief Financial Officer, marking a key executive transition. The leadership change comes as FactSet rolls out new AI powered banking solutions and deepens its partnership with Finster AI. FactSet enters this CFO transition with NYSE:FDS trading at $222.97 and multi year returns that have been under pressure, including a 47.0% decline over the past year and a 24.2% decline over five years. For readers, that...

Select Water Solutions (WTTR) has drawn fresh attention after recent share price moves, with the stock last closing at $15.36. Investors are weighing this level against the company’s financial profile and water-focused energy services business. See our latest analysis for Select Water Solutions. Recent trading has added to a strong run, with a 10.34% 1 month share price return and a 36.65% 3 month share price return contributing to a 38.50% year to date share price gain. The 1 year total...

Alumis Inc. recently reported Phase 3 ONWARD1 and ONWARD2 data showing its oral TYK2 inhibitor envudeucitinib produced high rates of robust, durable skin clearance and quality-of-life improvements in adults with moderate-to-severe plaque psoriasis through Week 24, with a generally well-tolerated safety profile. An interesting aspect for investors is envudeucitinib’s maximal 24-hour TYK2 inhibition without fasting requirements, aiming to balance efficacy, convenience, and selective immune...

Praxis Precision Medicines (PRAX) is back on investors’ radar after it reported positive topline results from its EMBRAVE Part A trial of elsunersen in pediatric SCN2A developmental and epileptic encephalopathy. See our latest analysis for Praxis Precision Medicines. The positive elsunersen readout comes on top of recent progress with relutrigine, which is now under priority FDA review for certain developmental and epileptic encephalopathies. This has helped support an 8.78% 90-day share...

NMI Holdings recently announced a US$250.00 million share repurchase program running through December 2027, following a period of consistent earnings outperformance and solid operating results that have strengthened investor confidence. This combination of disciplined capital returns and robust fundamental execution underscores management’s focus on enhancing shareholder value while reinforcing the company’s position in the private mortgage insurance market. With this sizeable buyback plan...

Solstice Advanced Materials (SOLS) recently drew attention after Hudson Technologies signed a licensing agreement to reclaim and resell Solstice branded R-448A and R-449A refrigerants in the United States and Canada. See our latest analysis for Solstice Advanced Materials. Since early in the year, interest around Solstice Advanced Materials has lined up with stronger share price momentum, with a 90 day share price return of 59.95% and a year to date share price return of 69.14% alongside...

If you are wondering whether Aramark at around US$43.31 still offers value or is starting to look stretched, the next sections will walk through what the current price may be implying. The stock has seen returns of 3.4% over the last 7 days, 7.4% over 30 days, 18.4% year to date, 29.0% over 1 year, 77.4% over 3 years, and 61.4% over 5 years. This naturally raises questions about how much optimism is already in the price. Recent attention on Aramark has centered on how the business is...

In recent days, Wall Street analysts have become more positive on Enova International, revising earnings per share estimates higher and assigning the company a favorable Zacks Rank #2. This broad-based earnings optimism, highlighted by strong agreement among analysts, reflects increasing confidence in Enova’s business outlook and earnings resilience. With analysts revising earnings estimates upward, we’ll now examine how this growing confidence could reshape Enova International’s existing...

The United States market has experienced a notable upswing, climbing 3.0% in the last week and rising 26% over the past year, with earnings projected to grow by 16% annually. In this context of robust market performance, identifying stocks that may be trading below their estimated intrinsic value could offer investors potential opportunities for growth and value appreciation.

The United States market has shown robust performance, with a 3.0% rise over the last week and a 26% increase over the past year, while earnings are anticipated to grow by 16% annually in the coming years. In this thriving environment, growth companies with significant insider ownership can be particularly appealing as they often reflect strong confidence from those closest to the business.

The United States market has experienced a robust climb, rising 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In light of these conditions, identifying stocks with strong financials and growth potential is crucial for investors looking to capitalize on market opportunities. Although penny stocks may seem like an outdated term, they continue to represent smaller or newer companies that can offer significant value; this article highlights...

The United States market has shown robust performance, climbing 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors looking to capitalize on emerging trends.

The United States market has shown robust performance, with a 3.0% increase over the last week and a substantial 26% rise in the past year, as earnings are projected to grow by 16% annually. In this thriving environment, identifying dividend stocks that offer both reliable income and potential for growth can be an effective strategy for investors looking to capitalize on these favorable conditions.

Why UFP Technologies is on investors’ radar today Recent share price moves in UFP Technologies (UFPT), including a 6.2% gain over the past day and negative returns over the month and past 3 months, have drawn fresh attention to the medical packaging specialist. See our latest analysis for UFP Technologies. That 6.25% 1 day share price return has come after a weaker patch, with a 30 day share price return of 6.75% and a 90 day share price return of 21.51%. The 1 year total shareholder return...

On April 6, 2026, Barclays analyst Terry Ma reaffirmed an "Overweight" rating on SLM Corporation while adopting a more cautious outlook on the company. This shift in analyst sentiment, combined with upcoming first-quarter 2026 results announced for April 23, 2026, is prompting investors to reassess SLM's prospects. Now we’ll consider how Barclays’ more cautious stance, despite retaining a positive rating, may influence SLM’s existing investment narrative. The best AI stocks today may lie...

Delta Air Lines (DAL) opened 2026 with Q1 revenue of US$15.9b and a basic EPS loss of US$0.44, as net income swung to a loss of US$289m against a strong Q4 2025, when the company posted revenue of US$16.0b and basic EPS of US$1.88. Over the past year, revenue on a trailing basis has held near US$65.2b while basic EPS moved to US$6.89, and the trailing net profit margin of 6.9% sits above last year’s 5.9%. This provides a clearer view of how margins are trending through the current soft...

If you are wondering whether Grand Canyon Education at around US$171.76 is offering fair value or hiding a margin of safety, the next sections will help you frame that question clearly. The stock has returned 0.2% over the last 7 days, 6.6% over the last 30 days, 3.9% year to date, 0.9% over 1 year, 43.9% over 3 years and 51.6% over 5 years, which gives useful context before comparing the current price to underlying value. Recent coverage has focused on Grand Canyon Education as a US listed...

Satellogic (NasdaqCM:SATL) announced a $50 million at-the-market follow-on equity offering. The company plans to issue new shares over time into the open market, rather than in a single, fixed-price transaction. The offering size is material relative to a small-cap issuer and may affect capital structure and future funding flexibility. Satellogic focuses on high-frequency Earth observation, using a constellation of satellites to provide data and imagery to commercial and government...

Why Occidental Petroleum (OXY) is on investors’ radar Occidental Petroleum (OXY) has drawn fresh attention after recent trading left the shares at $59.77, set against a backdrop of mixed short term returns and a longer track record that includes both gains and setbacks. See our latest analysis for Occidental Petroleum. The recent 1 day share price return of a 5.04% decline contrasts with a 90 day share price return of 38.26% and a 1 year total shareholder return of 51.79%. This suggests...

Investors may be wondering whether Globe Life at US$147.85 is offering value right now, or if the recent share price move means they are late to the story. The stock has returned 5.3% over the last 7 days, 4.1% over the past month and 6.8% year to date, with a 21.6% return over 1 year, 41.4% over 3 years and 51.6% over 5 years. Recent coverage of Globe Life has focused on its position in the US insurance sector, with attention on how investors are weighing the stock against broader industry...

At its 2026 Investor Day held in March, JBT Marel Corporation outlined past synergy realization of US$43.00 million, detailed plans for further margin-enhancing savings by 2028, and highlighted its global manufacturing footprint as a potential buffer against tariff pressures. Management also signaled a renewed focus on disciplined acquisitions aimed at adding market-leading technologies, expanding full-line solutions, and increasing recurring revenue, with clear cash return hurdles by year...

If you are wondering whether Hormel Foods at around US$21.64 is a value opportunity or a value trap, this article walks through the numbers so you can judge that for yourself. The stock has seen a 1-year return decline of 23.9% and is down 46.0% over 5 years, which may have some investors asking whether current pricing reflects exaggerated pessimism or ongoing concerns. Recent coverage around Hormel Foods has focused on its role in the packaged foods space, including how brand strength and...

Yum China Holdings (NYSE:YUMC) released its 2025 Sustainability Report, outlining progress and new programs across food safety, environmental impact, and digital transformation. The report details initiatives such as using AI in food safety controls, collaborating with suppliers to curb emissions, and expanding the use of renewable energy. For anyone tracking NYSE:YUMC, this update adds a fresh layer of information beyond recent discussions around proxy issues, capital return, and...